Premium Nahrungsergänzungsmittel | artgerecht

Albumin-to-Creatinine Ratio – Kidney Test Explained

The albumin-to-creatinine ratio (ACR) is a urine test used to detect early kidney damage. It measures the amount of albumin relative to creatinine in a urine sample.

Regular tips about health Regular tips about health

Things worth knowing about "Albumin-to-Creatinine Ratio"

The albumin-to-creatinine ratio (ACR) is a urine test used to detect early kidney damage. It measures the amount of albumin relative to creatinine in a urine sample.

What Is the Albumin-to-Creatinine Ratio?

The albumin-to-creatinine ratio (ACR) is a laboratory measurement that expresses the relationship between the protein albumin and the waste product creatinine in a urine sample. Under normal circumstances, the kidneys retain albumin and allow very little of it to pass into the urine. When the kidneys are damaged, their filtering ability is impaired, and albumin leaks into the urine – a condition called albuminuria. The ACR is one of the most sensitive and practical tools available for detecting this leakage at an early stage.

How Is the Test Performed?

The ACR is measured using a single urine sample – typically the first morning urine, which provides the most consistent results. The laboratory measures both the albumin and creatinine concentrations in the sample and divides one by the other. This ratio compensates for variations in urine concentration caused by fluid intake or output, making it a more reliable indicator than measuring albumin alone. Results are expressed in mg of albumin per gram of creatinine (mg/g) or mg per mmol (mg/mmol).

Reference Values and Interpretation

ACR results are interpreted using internationally established thresholds:

Normal: ACR below 30 mg/g – no significant albuminuria
Moderately increased (microalbuminuria): ACR between 30 and 300 mg/g – early sign of kidney damage
Severely increased (macroalbuminuria): ACR above 300 mg/g – advanced kidney involvement

Because individual measurements can be temporarily affected by physical activity, infection, or fever, clinical guidelines recommend confirming an elevated result with two additional measurements within a three-month period.

When Is the ACR Used?

The ACR is primarily used for screening and monitoring in the following conditions:

Type 1 and Type 2 Diabetes: Regular ACR testing is a cornerstone of diabetes care, as diabetic kidney disease (diabetic nephropathy) often develops silently in its early stages.
High Blood Pressure (Hypertension): Chronically elevated blood pressure can damage the kidney filters and lead to albuminuria.
Chronic Kidney Disease (CKD): The ACR is a key parameter used to stage and monitor the progression of CKD.
Cardiovascular Risk Assessment: Elevated ACR is also recognized as an independent risk factor for heart attack and stroke.

Clinical Significance and Consequences

An elevated ACR is an early warning signal of glomerular damage – injury to the tiny filtering units of the kidney known as glomeruli. Early detection allows for timely interventions that can slow the progression of kidney disease and reduce cardiovascular risk. Treatment strategies may include optimizing blood pressure and blood sugar control, prescribing ACE inhibitors or angiotensin receptor blockers (ARBs), dietary modifications, and in some cases newer drug classes such as SGLT2 inhibitors.

Influencing Factors and Limitations

Several factors can temporarily affect ACR results and should be taken into account when interpreting findings:

Intense physical exercise shortly before sample collection
Urinary tract infections or fever
Menstruation
Severe heart failure
Markedly elevated blood pressure at the time of testing

For this reason, an elevated ACR should always be interpreted in the clinical context and confirmed with repeat measurements before any diagnosis is made.

References

Kidney Disease: Improving Global Outcomes (KDIGO) – KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 2022.
American Diabetes Association – Standards of Medical Care in Diabetes, Section on Diabetic Kidney Disease. Diabetes Care, 2024.
Levey AS, et al. – Chronic kidney disease as a global public health problem: approaches and initiatives. Nature Reviews Nephrology, 2007; 3(5):261–270.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.